Eiger Biopharmaceuticals, Inc.

CA · United States · Reporting entity ID 100000956831

Total reported 2019–2025

$4.91M

#711 of 2,960 reporting companies — 0% of all reported industry payments

$520K in general payments across 59 records, plus $4.18M in research funding across 582 records.

How it breaks down

General payments $519,638

Research funding $4,175,509

Ownership & investment $218,980

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.